Avecho Biotechnology (ASX: AVE) Share Price

AVE

$0.011▼-15.38%

$32.6MRank #1143 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$32.6M

Volume

11M

P/E Ratio

-2.5

EPS

-$0.0009

Dividend Yield

0.00%

52-Week High

$0.014

52-Week Low

$0.0035

Beta

1.198

Avecho Biotechnology (ASX: AVE) is an Australian-listed company in the Healthcare sector with a market capitalisation of $32.6M and the 1143rd-largest security on the ASX by market capitalisation. The AVE share price is $0.011, down 15.38% today and up 166.67% over the past 12 months. Shares have traded between $0.0035 and $0.014 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Avecho Biotechnology reported revenue of $957,727 and a net loss of $3.1M.

Charts

$0.01

24H Range

$0.011

$0.013

52-Week Range

$0.0035

$0.014

About Avecho Biotechnology Limited

Avecho Biotechnology Limited, an Australian biotech firm established in Clayton in 1992 (originally known as Phosphagenics until May 2019), specializes in the creation, manufacturing, and distribution of products leveraging its proprietary Targeted Penetration Matrix (TPM) drug delivery platform. This innovative system finds applications across diverse sectors including pharmaceuticals, skincare, animal wellness, and nutritional products. The company's offerings include its foundational TPM and Vital ET products, designed for use in both drug delivery and cosmetic formulations. Furthermore, Avecho is actively developing enhanced pharmaceutical solutions such as TPM/Oxymorphone and TPM/Oxycodone. Its human health division focuses on delivering therapeutic agents via various methods, including gels, injectable solutions, and transdermal patches. In the animal health domain, Avecho provides non-antibiotic feed supplements aimed at boosting the health and feed efficiency of livestock. Demonstrating a commitment to research, the company has partnered with the Lambert Initiative at the University of Sydney to investigate the efficacy of topically applied cannabidiol in alleviating osteoarthritis symptoms. Avecho serves a broad international clientele, with a presence in Australia, Switzerland, India, and beyond.

IPO Date

26 July 1999

CEO

Paul Gavin

Employees

Website

avecho.com.au

Key Financial Data

Revenue (Quarterly)	$957,727
Net Income (Quarterly)	$-3.1M
Total Assets	$7.1M
Total Debt	$14,473
Free Cash Flow	$-3.4M
Return on Equity	-197.39%
Profit Margin	-321.45%
Operating Margin	-449.43%

AVE Frequently Asked Questions

What is the Avecho Biotechnology (ASX: AVE) share price?

The AVE share price is $0.011, down 15.38% for the day, based on the latest available ASX market data.

What is Avecho Biotechnology's market capitalisation?

Avecho Biotechnology has a market capitalisation of $32.6M, making it the 1143rd-largest security listed on the ASX.

Does Avecho Biotechnology pay a dividend?

AVE does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Avecho Biotechnology profitable?

In its most recent reported period (ending 31 Dec 2025), AVE reported revenue of $957,727 and a net loss of $3.1M.

How many AVE shares are on issue?

Avecho Biotechnology has approximately 2,967,010,000 shares on issue, based on its market capitalisation of $32.6M and current share price.

What sector is Avecho Biotechnology in?

Avecho Biotechnology is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Avecho Biotechnology list on the ASX?

Avecho Biotechnology listed on the Australian Securities Exchange on 26 July 1999.

Latest News

Avecho Biotechnology (ASX: AVE) Moves Higher as Investors Monitor Development Progress

Kalkine5 June 2026

Avecho Biotechnology (ASX: AVE) Moves Higher as Investors Monitor Development Progress Kalkine

Why Is Avecho Biotechnology (ASX:AVE) Climbing Today?

Kalkine22 May 2026

Why Is Avecho Biotechnology (ASX:AVE) Climbing Today? Kalkine

Is Avecho Biotechnology (ASX:AVE) the Next ASX 300 Healthcare Stock in Focus?

Kalkine Media7 May 2026

Is Avecho Biotechnology (ASX:AVE) the Next ASX 300 Healthcare Stock in Focus? Kalkine Media

Avecho Biotechnology Limited (ASX:AVE)

intelligentinvestor.com.au27 Sept 2019

Avecho Biotechnology Limited (ASX:AVE) intelligentinvestor.com.au

Avecho Biotechnology (ASX:AVE) Reaches 52-Week High Ahead of Landmark Insomnia Trial Results

Kalkine11 May 2026

Avecho Biotechnology (ASX:AVE) Reaches 52-Week High Ahead of Landmark Insomnia Trial Results Kalkine

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
NC6Nanollose Limited	$18.6M	$0.053	-2.45	0.00%	–+0.00%
BTCBTC Health Limited	$16.1M	$0.052	-58.88	0.00%	–+0.00%
PABPatrys Limited	$14.7M	$0.043	-0.62	0.00%	▲+2.38%
NTINeurotech International Limited	$13.1M	$0.013	-5.30	0.00%	▲+8.33%
FREFirebrick Pharma Limited	$9.3M	$0.039	-2.55	0.00%	–+0.00%
IMCImmuron Limited	$8.8M	$0.034	-1.29	0.00%	▼-12.82%
TRPTissue Repair Ltd	$6.7M	$0.11	-2.68	0.00%	▲+4.76%
ENLEnlitic, Inc.	$5.8M	$0.007	0.00	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.012	$0.013	$0.012	$0.012	11M	–+0.00%
11 June 2026	$0.012	$0.013	$0.012	$0.012	5.7M	–+0.00%
10 June 2026	$0.013	$0.013	$0.012	$0.012	8M	▼-7.69%
9 June 2026	$0.012	$0.013	$0.012	$0.013	13M	–+0.00%
8 June 2026	$0.013	$0.013	$0.012	$0.013	11M	–+0.00%
5 June 2026	$0.013	$0.013	$0.012	$0.013	9.4M	▲+8.33%
4 June 2026	$0.012	$0.012	$0.012	$0.012	4.2M	–+0.00%
3 June 2026	$0.012	$0.012	$0.012	$0.012	6.2M	–+0.00%
2 June 2026	$0.011	$0.012	$0.011	$0.012	10M	▲+9.09%
1 June 2026	$0.012	$0.012	$0.011	$0.011	1.8M	–+0.00%
29 May 2026	$0.012	$0.012	$0.011	$0.011	15M	▼-8.33%
28 May 2026	$0.012	$0.013	$0.012	$0.012	2.1M	–+0.00%
27 May 2026	$0.012	$0.012	$0.012	$0.012	9.6M	▼-7.69%
26 May 2026	$0.013	$0.013	$0.012	$0.013	11M	▲+8.33%
25 May 2026	$0.013	$0.013	$0.012	$0.012	28M	▼-7.69%
22 May 2026	$0.013	$0.013	$0.012	$0.013	2.8M	▲+8.33%
21 May 2026	$0.013	$0.013	$0.012	$0.012	30M	–+0.00%
20 May 2026	$0.013	$0.013	$0.012	$0.012	3.3M	–+0.00%
19 May 2026	$0.013	$0.013	$0.012	$0.012	3.7M	▼-7.69%
18 May 2026	$0.013	$0.013	$0.013	$0.013	9.7M	–+0.00%
15 May 2026	$0.014	$0.014	$0.013	$0.013	616K	–+0.00%
14 May 2026	$0.014	$0.014	$0.013	$0.013	31M	–+0.00%
13 May 2026	$0.013	$0.013	$0.013	$0.013	16M	–+0.00%
12 May 2026	$0.013	$0.013	$0.013	$0.013	634K	▼-7.14%
11 May 2026	$0.013	$0.014	$0.013	$0.014	18M	▲+16.67%
8 May 2026	$0.012	$0.013	$0.012	$0.012	16M	–+0.00%
7 May 2026	$0.012	$0.013	$0.012	$0.012	7.1M	–+0.00%
6 May 2026	$0.012	$0.012	$0.012	$0.012	3.9M	▲+9.09%
5 May 2026	$0.013	$0.013	$0.011	$0.011	6.6M	▼-8.33%
4 May 2026	$0.012	$0.012	$0.012	$0.012	10M	▲+9.09%

About Avecho Biotechnology Limited

IPO Date

26 July 1999

CEO

Paul Gavin

Employees

Website

avecho.com.au

AVE Frequently Asked Questions

What is the Avecho Biotechnology (ASX: AVE) share price?

The AVE share price is $0.011, down 15.38% for the day, based on the latest available ASX market data.

What is Avecho Biotechnology's market capitalisation?

Avecho Biotechnology has a market capitalisation of $32.6M, making it the 1143rd-largest security listed on the ASX.

Does Avecho Biotechnology pay a dividend?

AVE does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Avecho Biotechnology profitable?

In its most recent reported period (ending 31 Dec 2025), AVE reported revenue of $957,727 and a net loss of $3.1M.

How many AVE shares are on issue?

Avecho Biotechnology has approximately 2,967,010,000 shares on issue, based on its market capitalisation of $32.6M and current share price.

What sector is Avecho Biotechnology in?

Avecho Biotechnology is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Avecho Biotechnology list on the ASX?

Avecho Biotechnology listed on the Australian Securities Exchange on 26 July 1999.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
NC6Nanollose Limited	$18.6M	$0.053	-2.45	0.00%	–+0.00%
BTCBTC Health Limited	$16.1M	$0.052	-58.88	0.00%	–+0.00%
PABPatrys Limited	$14.7M	$0.043	-0.62	0.00%	▲+2.38%
NTINeurotech International Limited	$13.1M	$0.013	-5.30	0.00%	▲+8.33%
FREFirebrick Pharma Limited	$9.3M	$0.039	-2.55	0.00%	–+0.00%
IMCImmuron Limited	$8.8M	$0.034	-1.29	0.00%	▼-12.82%
TRPTissue Repair Ltd	$6.7M	$0.11	-2.68	0.00%	▲+4.76%
ENLEnlitic, Inc.	$5.8M	$0.007	0.00	0.00%	–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.012	$0.013	$0.012	$0.012	11M	–+0.00%
11 June 2026	$0.012	$0.013	$0.012	$0.012	5.7M	–+0.00%
10 June 2026	$0.013	$0.013	$0.012	$0.012	8M	▼-7.69%
9 June 2026	$0.012	$0.013	$0.012	$0.013	13M	–+0.00%
8 June 2026	$0.013	$0.013	$0.012	$0.013	11M	–+0.00%
5 June 2026	$0.013	$0.013	$0.012	$0.013	9.4M	▲+8.33%
4 June 2026	$0.012	$0.012	$0.012	$0.012	4.2M	–+0.00%
3 June 2026	$0.012	$0.012	$0.012	$0.012	6.2M	–+0.00%
2 June 2026	$0.011	$0.012	$0.011	$0.012	10M	▲+9.09%
1 June 2026	$0.012	$0.012	$0.011	$0.011	1.8M	–+0.00%
29 May 2026	$0.012	$0.012	$0.011	$0.011	15M	▼-8.33%
28 May 2026	$0.012	$0.013	$0.012	$0.012	2.1M	–+0.00%
27 May 2026	$0.012	$0.012	$0.012	$0.012	9.6M	▼-7.69%
26 May 2026	$0.013	$0.013	$0.012	$0.013	11M	▲+8.33%
25 May 2026	$0.013	$0.013	$0.012	$0.012	28M	▼-7.69%
22 May 2026	$0.013	$0.013	$0.012	$0.013	2.8M	▲+8.33%
21 May 2026	$0.013	$0.013	$0.012	$0.012	30M	–+0.00%
20 May 2026	$0.013	$0.013	$0.012	$0.012	3.3M	–+0.00%
19 May 2026	$0.013	$0.013	$0.012	$0.012	3.7M	▼-7.69%
18 May 2026	$0.013	$0.013	$0.013	$0.013	9.7M	–+0.00%
15 May 2026	$0.014	$0.014	$0.013	$0.013	616K	–+0.00%
14 May 2026	$0.014	$0.014	$0.013	$0.013	31M	–+0.00%
13 May 2026	$0.013	$0.013	$0.013	$0.013	16M	–+0.00%
12 May 2026	$0.013	$0.013	$0.013	$0.013	634K	▼-7.14%
11 May 2026	$0.013	$0.014	$0.013	$0.014	18M	▲+16.67%
8 May 2026	$0.012	$0.013	$0.012	$0.012	16M	–+0.00%
7 May 2026	$0.012	$0.013	$0.012	$0.012	7.1M	–+0.00%
6 May 2026	$0.012	$0.012	$0.012	$0.012	3.9M	▲+9.09%
5 May 2026	$0.013	$0.013	$0.011	$0.011	6.6M	▼-8.33%
4 May 2026	$0.012	$0.012	$0.012	$0.012	10M	▲+9.09%